(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-amino-2-methylpentanoic acid hydrochloride is a chiral amino acid derivative. It serves as a key intermediate in the synthesis of Sacubitril, a neprilysin inhibitor. Sacubitril is a critical component of the blockbuster cardiovascular drug Entresto (sacubitril/valsartan), which is used for the treatment of heart failure with reduced ejection fraction. This compound is specifically designed as a building block for constructing the complex, pharmacologically active molecule. Its chiral centers ((2R,4S) configuration) are essential for the biological activity of the final API. The synthesis and supply of this high-purity intermediate are crucial steps in the manufacturing process of Sacubitril. The compound is typically handled under controlled conditions in pharmaceutical R&D and production settings. Its primary value lies in its role as a specialized precursor, rather than as a general-purpose chemical reagent.